Director, Integrated Evidence Planning

Major accountabilities:

• Cross-divisionally, facilitate and coordinate the Integrated Evidence Plan process for priority products.
• In collaboration with cross-functional therapeutic area teams including but not limited to therapeutic area RWE & Innovative Evidence, Development, Medical, Access, HE&OR and key country stakeholders, facilitate prioritization of evidence gaps and targeted evidence generation projects.
• Implement value framework in IEP development to contribute to decision making and assess business value drivers and success metrics 
• Facilitate key country input into the global Integrated Evidence Plan
• Ensure integrate evidence gaps and their solutions are prioritized and pressure-tested with external decision makers
• Ensure feedback from key internal stakeholders and IEP squad members on the IEP process is regularly collected and utilized to ensure continuous process improvement, including contribution to enabling technology solutions, templates, workshops, platforms, etc.
• Act as a thought-leader and internal change agent on matters pertaining to the overall Integrated Evidence Planning process.
• Ask the right scientific questions, understand the evidence needs to optimize approval, access and clinical adoption of our medicines, and ideate and make recommendations on fit-for-purpose data and integrated evidence solutions.
• Develop strong internal and external partnerships to promote effective collaborations and prioritization negotiations. Lead by example in promoting a collaborative and entrepreneurial culture and mindset. Be an advocate and champion by engaging support for innovative ideas and solutions and ensuring a broad understanding of the value of RWE and integrated evidence to the product value demonstration both globally and in key markets.

Minimum Requirements:

• 15+ years biopharmaceutical industry experience
• Fluent English (spoken and written)
• Prior experience leading the creation of cross-functional evidence generation strategic planning.
• Deep understanding of stakeholder (regulatory, HTA, healthcare practitioners, and patient) evidentiary needs.
• Strong leadership skills, with an ability to motivate and inspire teams and manage change.
• Deep understanding and experience conducting  interventional and non-interventional studies to generate scientifically rigorous and impactful evidence, both from prospective and retrospective studies, including secondary data sources.
• Strong understanding of drug development with proven ability to identify and deliver impactful evidence from retrospective and prospective studies to optimize regulatory approval, market access and clinical adoption.
• Strong cross-functional experience working with Clinical Development, Commercial, Market Access, HEOR, Medical, Safety, Regulatory colleagues and local affiliates.
• Considerable experience in collaborating with quantitative scientists and analysts.
• Proven ability to develop and successfully implement new strategies and ideas.
• Strong communication skills. Proven ability to translate and effectively communicate complex technical concepts and innovative evidence solutions to diverse audiences.
• Robust organizational, interpersonal, collaboration and influencing skills
• Results focused, ability to meet difficult timelines in a dynamic environment
• Must be able to organize, prioritize and work effectively in a constantly changing environment.

Closing date for applications: 16 July 2024.